| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $950K | — | -22.4% |
| Cost of Revenue | $160K | — | +6.7% |
| Gross Profit | $790K | -11.0% | -26.4% |
| R&D Expense | $1.5M | — | +1.8% |
| SG&A Expense | $2.3M | — | +12.1% |
| Operating Income | -$4.1M | — | -10.1% |
| Pre-tax Income | -$4.0M | — | -147.6% |
| Income Tax | $2K | — | — |
| Net Income | -$4.0M | +28.0% | -147.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.3M | +11.2% | +217.0% |
| Accounts Receivable | $907K | +15.0% | +23.9% |
| Current Assets | $14.2M | +10.6% | +166.8% |
| Total Assets | $33.0M | +1.7% | +12.8% |
| Current Liabilities | $6.2M | +7.9% | -33.5% |
| Total Liabilities | $17.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | — | -125.7% |
| Capital Expenditures | $5K | — | +0.0% |
| Investing Cash Flow | -$5K | — | +0.0% |
| Financing Cash Flow | $3.5M | — | — |
| Free Cash Flow | -$2.2M | — | -125.1% |
| +24.8% |
| Stockholders' Equity | $15.9M | +14.0% | +2.2% |